Search for: "Wells Fargo v. Long (Complete Opinion)" Results 21 - 40 of 41
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2016, 10:22 am by John Elwood
Wells Fargo Bank v. [read post]
3 Feb 2016, 8:57 am by Dennis Crouch
Wells Fargo Bank, National Association, et al., No. 14-1473 W.L. [read post]
8 Oct 2015, 4:05 pm
They owed Wells Fargo Bank more than $228,000 on a first mortgage and MidFirst Bank more than $67,000 on a second mortgage. [read post]
4 Jan 2012, 12:33 am by Kevin LaCroix
Corporate defendants, eager to complete the underlying business transaction, often are keen to settle these cases quickly. [read post]
30 Nov 2011, 2:15 pm by Mandelman
 JP Morgan Chase went from A+ to A; Goldman Sachs, Bank of America, Morgan Stanley and Citigroup were downgraded from A to A-; and Wells Fargo was cut from AA- to A+. [read post]
6 Sep 2011, 1:56 am by Kevin LaCroix
  Supreme Court Issues Key Rulings: It already seems like a long time ago, but at the end of the Supreme Court’s term in June, the Court issued its opinions in several key cases. [read post]
15 Jun 2011, 1:25 am by Mandelman
PART 1 “We are now well into the fourth year of the foreclosure crisis, and there is no end in sight. [read post]
22 Dec 2010, 11:36 am by stevemehta
The long form agreement—so we can get that part of it consummated as well. [read post]
13 Oct 2010, 12:00 pm by Stefanie Levine
  The long-standing prohibition against the use of settlement license agreements stems from two broad categories: (1) evidentiary or policy grounds and (2) lack of probative value. [read post]
19 Aug 2010, 2:50 pm by THE KONG FIRM PLLC
  It seems pretty clear that the risk ofliability decreases for employers that have conducted complete and thorough background checks. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]